Growing Number of Drug Developments and Regulatory Approvals Drives Crohn’s Disease Therapeutics Market Growth The majority of the established as well as new players are making efforts to manufacture drugs against Crohn’s disease. In 2023, the US Food and Drug Administration (FDA) approved the first pill—Rinvoq (upadacitinib)—to treat moderate-to-severe Crohn’s disease in adults who are […]